Information on Research Study

SNo Date Information Download
# 18/01/2022* Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG))
# 14/01/2022* Clinical Guidance for Management of Adult COVID-19 Patients
# 08/11/2021* Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG))
# 02/08/2021* Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG))
# 28/06/2021* Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG))
# 06/08/2020 Invitation for submitting Letter of Intent for Participation in National Clinical Registry of COVID-19
# 30/07/2020 Agenda of International Symposium on Novel Ideas in Science and Ethics of Vaccines against COVID-19 pandemic on July 30, 2020
# 23/07/2020 Establishing of a network of Biorepositories in India
# 23/05/2020 Establishing of a network of Biorepositories in India
# 22/05/2020 Establishing of a network of Biorepositories in India
# 22/05/2020 List of approved institutions for PLACID Trial
# 15/05/2020 List of approved institutions for PLACID Trial
# 11/05/2020 List of approved institutions for PLACID Trial
# 10/05/2020 List of approved institutions for PLACID Trial
# 08/05/2020 List of approved institutions for PLACID Trial
# 04/05/2020 List of approved institutions for PLACID Trial
# 21/04/2020* Call for proposals under the TF on Translational Immunology
# 12/04/2020 Call for Letter of Intent for Participation in: Therapeutic Plasma Exchange in COVID-19: Protocol for a Multi-center, Phase II, Open Label, Randomized Controlled Study
# 12/04/2020 Call for Letter of Intent for Participation in: A Phase II, Open Label, Randomized Controlled Study to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications
# 03/04/2020 Therapeutic trial for COVID-19

Guidelines

SNo Date Information Download
# 23/09/2021 Clinical Guidance for Management of Adult COVID-19 Patients
# 17/05/2021 Clinical Guidance for Management of Adult COVID-19 Patients
# 18/01/2021* Restricted Use of COVAXINTM Under Clinical Trial Mode (Implementation Plan No: BBIL/COVAXINTM/2021)
# 26/11/2020 Advisory on use of Dry Swab RNA Extraction Free RTPCR Method
# 22/03/2020 Recommendation for empiric use of hydroxy-chloroquine for prophylaxis of SARS-CoV-2 infection
*Date of Publishing on Website

Website Content Owned by
Indian Council of Medical Research, DHR, MoHFW, GoI

Website Hosted By :
National Informatics Centre